MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Exploring The Role of a Prescribing Pharmacist in the Management of Parkinson’s Disease

    E. Wong (London, United Kingdom)

    Objective: Aims/Objectives A review to explore the role of a pharmacist NMP within the neurology PD multidisciplinary team during a six month period between 1st…
  • 2018 International Congress

    Effects of Aquatic Physical Therapy on Parkinson’s disease under a vision of the International Classification of Functioning, Disability and Health (ICF)

    V. Israel, B. Yamaguchi, M. Ferreira (Curitiba, Brazil)

    Objective: The objective of the study was to verify the effects of APT on functional abilities of people with PD. Background: In the biopsychosocial model…
  • 2018 International Congress

    Eye movement disorders after cerebellar infaction

    M. Munteanu (Bucharest, Romania)

    Objective: This study aims to demostrate that the posterior cerebellar vermis controls both saccade precision and smooth pursuit velocity in humans. Background: The posterior vermis…
  • 2018 International Congress

    A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

    T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: The aim of this study is to create mouse models reproducing the course of PD pathology and symptoms. Background: Parkinson's disease (PD) is a…
  • 2018 International Congress

    Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?

    A. Mook, S. Gunzler, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy? Background: Increased serum titers of antiGAD antibody can be seen…
  • 2018 International Congress

    Rotenone model of Parkinson’s disease: The dosing options in mice revisited

    M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

    Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…
  • 2018 International Congress

    Parkinson’s disease-related non-motor features as risk factors for post-operative delirium in spinal surgery

    SY. Kang, KH. Kim, DA. Shim, SW. Choi, MJ. Son, YH. Sohn, PH. Lee (Hwaseong, Republic of Korea)

    Objective: We investigated the association between PD-related NMSs and postoperative delirium in old people undergoing elective spinal surgery. Background: The clinical features of postoperative delirium…
  • 2018 International Congress

    Acoustic, respiratory, cognitive and wellbeing comparisons of two groups of people with Parkinson’s disease participating in voice and choral singing group therapy (VCST) versus a music appreciation activity

    R. Matthews, S. Purdy, L. Tippett (Auckland, New Zealand)

    Objective: The aim of this two armed RCT is to evaluate how intensive singing improves the phonatory and respiratory muscle control of people with Parkinson's…
  • 2018 International Congress

    Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel

    E. Saka Topcuoglu, L. Mehdikhanova, E. Arsava, M. Topcuoglu, B. Elibol (Ankara, Turkey)

    Objective: We report a case that developed cerebral and pulmonary thromboembolism during 24-hour levodopa/carbidopa intestinal gel (LCIG) infusion. Background: LCIG is a therapeutic option in…
  • 2018 International Congress

    The epiphenomenon of movement disorders post-stroke period

    J. Shodmonov, B. Muinjanov (Tashkent, Uzbekistan)

    Objective: The goal of this study is to describe the clinical, paraclinical and evolutive features of patients having suffered from a movement disorder in the…
  • « Previous Page
  • 1
  • …
  • 1281
  • 1282
  • 1283
  • 1284
  • 1285
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley